Dietmar Berger - 02 Jan 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Medical Officer
Signature: /s/ Edward S. Son by Power of Attorney for Dietmar Berger
Issuer symbol: GILD
Transactions as of: 02 Jan 2026
Net transactions value: -$844,390
Form type: 4
Filing time: 05 Jan 2026, 17:56:33 UTC
Previous filing: 12 Mar 2025
Next filing: 02 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Berger Dietmar	Chief Medical Officer	333 LAKESIDE DR., FOSTER CITY	/s/ Edward S. Son by Power of Attorney for Dietmar Berger	05 Jan 2026	0001739515

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+16,326			16,326	02 Jan 2026	Direct	F1
transaction	GILD	Common Stock	Tax liability	$844,390	-6,944	-43%	$121.60	9,382	02 Jan 2026	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-16,326	-28%		41,179	02 Jan 2026	Common Stock	16,326		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units vest in approximately three equal installments on the first three anniversaries of the date of grant until fully vested.